Abstract
The updated 2014 ESC guidelines on myocardial revascularization did indeed impact on current practice. Some of the most important changes are summarized in this review. Importantly, the recommendation for dual antiplatelet therapy after stenting in stable patients was reduced to 6 months. Also, a more liberal use of PCI in left main stem disease was proposed by the ESC guideline committee.
© Georg Thieme Verlag KG Stuttgart · New York.
MeSH terms
-
Absorbable Implants / trends
-
Acute Coronary Syndrome / therapy
-
Angina, Stable / therapy
-
Cardiovascular Diseases / therapy*
-
Drug-Eluting Stents
-
Europe
-
Humans
-
Myocardial Ischemia / therapy
-
Myocardial Revascularization* / methods
-
Myocardial Revascularization* / standards
-
Myocardial Revascularization* / trends
-
Platelet Aggregation Inhibitors / administration & dosage*
-
Platelet Aggregation Inhibitors / classification
-
Practice Guidelines as Topic*
Substances
-
Platelet Aggregation Inhibitors